NGL Fine-Chem
Ticker > Company >

NGL Fine-Chem share price

NGL Fine-Chem Ltd.

  59.66 K   256   40 NSE: NGLFINE BSE: 524774 SECTOR: Pharmaceuticals & Drugs

2937.00
-525.60 (-15.18%)
BSE: Today, 04:01 PM

Buy on Angel One

Price Summary

Today's High

₹ 3515.85

Today's Low

₹ 2792.45

52 Week High

₹ 3595

52 Week Low

₹ 1261

FinStar

Ownership Below Par
Stock price may face volatility due to ownership structure.
ValuationFair
The stock’s market price justifies its intrinsic value.
EfficiencyOptimal
The company could improve upon its asset employment.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

₹ 1814.49 Cr.

Enterprise Value

₹ 1933.34 Cr.

No. of Shares

0.62 Cr.

P/E

35.97

P/B

5.39

Face Value

₹ 5

Div. Yield

0.06 %

Book Value (TTM)

₹  544.49

CASH

₹ 2.75 Cr.

DEBT

₹ 121.6 Cr.

Promoter Holding

72.49 %

EPS (TTM)

₹  81.64

Sales Growth

36.04%

ROE

13.89 %

ROCE

14.96%

Profit Growth

129.61 %

Add Your Ratio

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.

PE Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

PB Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year36.04%
3 Year21.12%
5 Year13.62%

Profit Growth

1 Year129.61%
3 Year27.6%
5 Year-5.53%

ROE%

1 Year13.89%
3 Year12.12%
5 Year14.91%

ROCE %

1 Year14.96%
3 Year14.06%
5 Year17.68%

Debt/Equity

0.3801

Price to Cash Flow

52.24

Interest Cover Ratio

11.8598

CFO/PAT (5 Yr. Avg.)

0.677197242763074

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2026 72.49 0.00
Mar 2026 72.74 0.00
Dec 2025 72.74 0.00
Sep 2025 72.74 0.00
Jun 2025 72.74 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good profit growth of 27.4312990401672% for the Past 3 years.
  • The company has shown a good revenue growth of 21.1239266427617% for the Past 3 years.
  • Company has a healthy Interest coverage ratio of 11.8598.
  • Company’s PEG ratio is 0.277559340523051.
  • The company has an efficient Cash Conversion Cycle of 38.5724 days.
  • The company has a high promoter holding of 72.49%.

 Limitations

 Looks like the company does not have any serious limitations.

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Net Sales 100.86 116.84 126.33 144.75 136.71
Total Expenditure 93.04 103.18 106.24 127.15 116.93
Operating Profit 7.82 13.66 20.09 17.6 19.78
Other Income 6.55 2.41 4.69 2.51 7.36
Interest 1.21 1.15 1.06 1 0.97
Depreciation 3.45 4.26 4.35 4.24 4.43
Exceptional Items 0 0 0 0 0
Profit Before Tax 9.72 10.66 19.37 14.88 21.75
Tax 2.07 2.76 4.64 3.52 5.29
Profit After Tax 7.65 7.9 14.74 11.36 16.45
Adjusted EPS (Rs) 12.37 12.78 23.85 18.38 26.63

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Net Sales 318.67 275.05 328.97 359.29 488.77
Total Expenditure 252.75 246.34 284.21 332.72 427.68
Operating Profit 65.92 28.71 44.76 26.57 61.09
Other Income 12.64 7.61 15.9 9.76 14.85
Interest 1.91 1.83 1.8 3.18 5.03
Depreciation 7.67 7.9 8.15 9.27 16.3
Exceptional Items 0 0 0 0 0
Profit Before Tax 68.97 26.6 50.71 23.88 54.62
Tax 16.73 6.48 12.19 5.75 12.99
Net Profit 52.19 20.04 38.37 18.13 41.63
Adjusted EPS (Rs.) 84.57 32.57 62.35 29.35 67.39

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity and Liabilities
Share Capital 3.09 3.09 3.09 3.09 3.09
Total Reserves 203.48 222.43 259.72 276.52 316.85
Borrowings 3.44 2.07 0.74 25.34 56.4
Other N/C liabilities 4.6 3.87 5.13 14.15 9.25
Current liabilities 63.12 56.65 84.36 112.96 156.62
Total Liabilities 277.72 288.11 353.05 432.06 542.21
Assets
Net Block 58.68 59.49 60.13 119.89 144.03
Capital WIP 6.31 26.31 45.52 49.73 94.57
Intangible WIP 0 0 0 0 0
Investments 3.73 3.73 3.73 3.73 3.73
Loans & Advances 36.4 35.01 35.36 29.17 17.32
Other N/C Assets 2.57 4.39 4.62 1.99 4.73
Current Assets 170.04 159.19 203.69 227.56 277.83
Total Assets 277.72 288.11 353.05 432.06 542.21
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Profit from operations 68.97 26.6 50.71 23.88 54.62
Adjustment 6.63 5.91 -1.12 8.7 21.92
Changes in Assets & Liabilities -43.06 5.86 -26.26 -4.85 -28.83
Tax Paid -16.73 -6.48 -12.19 -5.75 -12.99
Operating Cash Flow 15.82 31.89 11.14 21.99 34.73
Investing Cash Flow -16.13 -23.62 -17.49 -58.2 -64.57
Financing Cash Flow -1.08 -1.08 -1.08 36.35 29.87
Net Cash Flow -1.4 7.19 -7.44 0.14 0.03

Corporate Actions

Investors Details

PARTICULARS Jun 2025% Sep 2025% Dec 2025% Mar 2026% Jun 2026%
promoters 72.74 72.74 72.74 72.74 72.49
ajita rahul nachane - - - 11.55 11.55
pci ferrmone chemicals in... - - - 8.38 8.38
rahul jayant nachane - - - 17.54 17.54
rajesh narayan lawande - - - 21.89 21.89
sunita sandeep potdar - - - 13.38 13.14
ajita nachane 11.55 11.55 11.55 - -
pci ferrmone chemicals (i... - - 8.38 - -
rahul nachane 17.54 17.54 17.54 - -
rajesh lawande 21.89 21.89 21.89 - -
sunita potdar 13.38 13.38 13.38 - -
pci ferrmone chemicals (i... - 8.38 - - -
pci ferrmone chemicals (i... 8.38 - - - -
PARTICULARS Jun 2025% Sep 2025% Dec 2025% Mar 2026% Jun 2026%
investors 27.26 27.26 27.26 27.26 27.51
llp 0.04 0.04 0.04 0.04 0.22

Annual Reports

Title Link
Title Link
Annual Report 2025
Annual Report 2024
Annual Report 2021
Annual Report 2020
Annual Report 2019
Annual Report 2018
Annual Report 2017

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
Credit ICRA
Credit CRISIL
Credit CRISIL
Credit CRISIL
Credit CRISIL
Credit CRISIL
Credit CRISIL
Credit ICRA
Credit CRISIL
Credit ICRA
Credit ICRA
Credit ICRA
Credit CRISIL
TYPE AGENCY Link
TYPE AGENCY Link
 No Research reports exist for this company.Report us

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
Concall Q2FY26
Concall Q2FY24
Concall Q1FY21
TYPE QUARTER Link
TYPE QUARTER Link
Presentation Q4FY24
Presentation Q4FY22
Presentation Q4FY21
Presentation Q4FY21
Presentation Q3FY24
Presentation Q3FY23
Presentation Q3FY22
Presentation Q2FY24
Presentation Q2FY23
Presentation Q2FY22
Presentation Q1FY25
Presentation Q1FY22

Company News

NGL Fine Chem informs about compliances-certificate 13 Jul, 5:33 PM NGL Fine-Chem informs about credit rating 13 Mar, 1:03 PM NGL Fine-Chem informs about certificate 3 Jan, 1:12 PM NGL Fine-Chem - Quaterly Results 1 Aug, 8:08 PM NGL Fine-Chem - Quaterly Results 1 Aug, 8:08 PM NGL Fine-Chem submits BRSR 25 Jul, 5:17 PM NGL Fine Chem informs about compliance certificate 10 Jul, 6:15 PM NGL Fine-Chem informs about credit rating 27 Jun, 12:33 PM NGL Fine-Chem - Quaterly Results 22 May, 8:07 PM NGL Fine-Chem - Quaterly Results 22 May, 8:07 PM NGL Fine Chem informs about disclosure 19 Apr, 4:25 PM Ngl Fine-Chem informs about credit rating 6 Mar, 4:45 PM NGL Fine-Chem informs about outcome of board meeting 6 Mar, 12:37 PM NGL Fine-Chem informs about newspaper publication 10 Feb, 5:14 PM NGL Fine-Chem - Quaterly Results 7 Feb, 7:33 PM NGL Fine-Chem - Quaterly Results 7 Feb, 7:33 PM Ngl Fine-Chem informs about updates 6 Jan, 5:25 PM Ngl Fine-Chem informs about disclosure 23 Sep, 5:21 PM NGL Fine-Chem informs about disclosure 19 Aug, 12:59 PM NGL Fine-Chem informs about newspaper publication 16 Aug, 5:37 PM NGL Fine-Chem - Quaterly Results 12 Aug, 7:09 PM NGL Fine-Chem - Quaterly Results 12 Aug, 7:09 PM Ngl Fine-Chem informs about disclosure 18 Jun, 6:06 PM NGL Fine-Chem submits analyst meet outcome 1 Jun, 3:54 PM NGL Fine-Chem informs about revised investor presentation 28 May, 3:31 PM NGL Fine-Chem - Quaterly Results 21 May, 8:08 PM NGL Fine-Chem - Quaterly Results 21 May, 8:08 PM NGL Fine-Chem informs about issuance of letter of confirmation 2 May, 5:29 PM NGL Fine-Chem submits postal ballot notice 19 Mar, 11:08 AM NGL Fine-Chem informs about board meeting 11 Mar, 5:09 PM NGL Fine-Chem - Quaterly Results 12 Feb, 7:04 PM NGL Fine-Chem - Quaterly Results 12 Feb, 7:04 PM NGL Fine-Chem informs about board meeting 3 Feb, 11:54 AM Ngl Fine-Chem informs about loss of share certificate 16 Jan, 5:25 PM NGL Fine-Chem informs about issuance of letter of confirmation 1 Jan, 12:22 PM NGL Fine-Chem informs about investor presentation 17 Nov, 2:25 PM NGL Fine-Chem - Quaterly Results 10 Nov, 6:57 PM Ngl Fine-Chem informs about investor meet 8 Nov, 4:30 PM NGL Fine-Chem informs about closure of trading window 28 Sep, 2:35 PM NGL Fine-Chem informs about disclosure 18 Sep, 10:27 AM NGL Fine-Chem informs about disclosure 13 Sep, 2:02 PM NGL Fine-Chem informs about disclosure 11 Sep, 1:16 PM NGL Fine-Chem informs about disclosure 8 Sep, 5:20 PM NGL Fine-Chem - Quaterly Results 4 Aug, 7:17 PM NGL Fine-Chem - Quaterly Results 4 Aug, 7:17 PM NGL Fine-Chem informs about details of loss of certificate 28 Jul, 4:29 PM NGL Fine-Chem informs about credit rating 18 Jul, 2:19 PM NGL Fine-Chem informs about closure of trading window 28 Jun, 4:40 PM NGL Fine-Chem informs about details of loss of certificate 6 Jun, 12:31 PM NGL Fine-Chem - Quaterly Results 15 May, 6:24 PM

NGL Fine-Chem Stock Price Analysis and Quick Research Report. Is NGL Fine-Chem an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse NGL Fine-Chem. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). NGL Fine-Chem has a PE ratio of 35.6228611462909 which is high and comparatively overvalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. NGL Fine-Chem has ROA of 8.5463% which is a bad sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. NGL Fine-Chem has a Current ratio of 1.774.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. NGL Fine-Chem has a ROE of 13.8878%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. NGL Fine-Chem has a Debt to Equity ratio of 0.3801 which means that the company has low proportion of debt in its capital.

  • Sales growth: NGL Fine-Chem has reported revenue growth of 36.0375% which is fair in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of NGL Fine-Chem for the current financial year is 12.4994015636681%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for NGL Fine-Chem is Rs 1.75 and the yield is 0.0546%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of NGL Fine-Chem is Rs 81.6442. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of NGL Fine-Chem in Ticker for free. Also, one can get the intrinsic value of NGL Fine-Chem by using Valuation Calculators, which are available with a Finology ONE subscription. 

NGL Fine-Chem FAQs

Q1. What is NGL Fine-Chem share price today?
Ans: The current share price of NGL Fine-Chem is Rs 2908.4.

Q2. What is the market capitalisation of NGL Fine-Chem?
Ans: NGL Fine-Chem has a market capitalisation of Rs 1796.81650016 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of NGL Fine-Chem?
Ans: The PE ratio of NGL Fine-Chem is 35.6228611462909 and the P/B ratio of NGL Fine-Chem is 5.34150439272803, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of NGL Fine-Chem share?
Ans: The 52-week high share price of NGL Fine-Chem is Rs 3602, and the 52-week low share price of NGL Fine-Chem is Rs 1271.

Q5. Does NGL Fine-Chem pay dividends?
Ans: Currently, NGL Fine-Chem pays dividends. Dividend yield of NGL Fine-Chem is around 0.0546%.

Q6. What are the face value and book value of NGL Fine-Chem shares?
Ans: The face value of NGL Fine-Chem shares is Rs 5, while the book value per share of NGL Fine-Chem is around Rs 544.4908. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of NGL Fine-Chem?
Ans: NGL Fine-Chem has a total debt of Rs 121.6035 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of NGL Fine-Chem?
Ans: The ROE of NGL Fine-Chem is 13.8878% and ROCE of NGL Fine-Chem is 14.9635%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is NGL Fine-Chem a good buy for the long term?
Ans: The NGL Fine-Chem long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is NGL Fine-Chem undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the NGL Fine-Chem appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check NGL Fine-Chem’s financials?
Ans: You can review NGL Fine-Chem’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about NGL Fine-Chem

NGL Fine-Chem Limited Financials: Check Share Price, Balance Sheet, Annual Report, Quarterly Results, Shareholding, Company Profile and News for Company Analysis

NGL Fine-Chem Limited is a leading company in the chemical industry, specializing in the manufacturing and distribution of fine chemicals. With a strong presence in both domestic and international markets, NGL Fine-Chem Limited has established itself as a trusted name in the industry.

NGL Fine-Chem Limited - Share Price

Get real-time updates on NGL Fine-Chem Limited's share price, ensuring you stay informed and make well-informed investment decisions. Our pre-built screening tools allow you to easily track the performance of NGL Fine-Chem Limited's stock and analyze historical trends.

NGL Fine-Chem Limited - Balance Sheet

Analyze NGL Fine-Chem Limited's financial health through its balance sheet. Our premium features enable you to calculate the fair value of the company using various tools, such as DCF Analysis, BVPS Analysis, Earnings Multiple Approach, and DuPont Analysis. These tools provide valuable insights for long-term stock investors seeking in-depth stock analysis.

NGL Fine-Chem Limited - Annual Report

Access NGL Fine-Chem Limited's annual reports on our website. These comprehensive documents provide a detailed overview of the company's performance, strategy, and outlook. With downloadable annual reports, you can study NGL Fine-Chem Limited's financials at your convenience and make informed investment decisions.

NGL Fine-Chem Limited - Dividend

Stay up-to-date with NGL Fine-Chem Limited's dividend announcements. Our platform allows you to easily track dividend history and projections, helping you assess the company's dividend yield and potential returns. For long-term investors seeking stable income streams, NGL Fine-Chem Limited's dividend information is a valuable resource.

NGL Fine-Chem Limited - Quarterly Result

Monitor NGL Fine-Chem Limited's quarterly performance through our platform. Explore the company's financials and assess its growth trajectory. Our premium features enable you to evaluate the fair value of NGL Fine-Chem Limited's stock using a variety of analytical tools, providing a comprehensive analysis for long-term investors.

NGL Fine-Chem Limited - Stock Price

Stay updated with real-time stock prices of NGL Fine-Chem Limited. Through our platform, you can easily track the stock's performance and analyze historical price movements. Our pre-built screening tools allow you to identify trends and make informed investment decisions with ease.

NGL Fine-Chem Limited - Price Chart

Visualize NGL Fine-Chem Limited's stock performance with interactive price charts. Our platform provides comprehensive price charts that enable you to identify patterns, trends, and potential opportunities. Long-term investors can utilize these charts to make well-informed decisions based on historical trends and future projections.

NGL Fine-Chem Limited - News

Access the latest news and updates about NGL Fine-Chem Limited through our platform. Stay informed about important developments that may impact the company's stock performance. Our curated news section ensures you have access to relevant and timely information, empowering you to make informed investment decisions.

NGL Fine-Chem Limited - Concall Transcripts

Gain insights into NGL Fine-Chem Limited's conference call discussions with our downloadable concall transcripts. These transcripts provide a comprehensive record of management's remarks, investor questions, and key takeaways. Stay informed about the company's strategic initiatives, performance updates, and future plans through these valuable resources.

NGL Fine-Chem Limited - Investor Presentations

Access NGL Fine-Chem Limited's investor presentations on our website. These presentations provide a detailed overview of the company's operations, financials, and growth strategies. Stay updated on NGL Fine-Chem Limited's achievements, market positioning, and future prospects through these informative presentations.

NGL Fine-Chem Limited - Promoters

Understand the key individuals behind NGL Fine-Chem Limited's success. Our platform provides detailed information about NGL Fine-Chem Limited's promoters, allowing you to assess their experience, expertise, and influence on the company's performance. Gain insights into the leadership team that drives NGL Fine-Chem Limited's growth and success.

NGL Fine-Chem Limited - Shareholders

Explore NGL Fine-Chem Limited's shareholder information and ownership structure. Understand the major stakeholders and their influence on the company's decision-making processes. Our platform provides valuable insights into the distribution of ownership, enabling you to assess the stability and governance structure of NGL Fine-Chem Limited.

With a commitment to serving long-term stock investors, NGL Fine-Chem Limited offers a comprehensive stock analysis platform. Through our pre-built screening tools and premium features, you can analyze the company's performance, assess fair value using various tools, and access essential resources such as annual reports, concall transcripts, investor presentations, and credit ratings. Stay informed, make informed investment decisions, and maximize your returns with NGL Fine-Chem Limited's stock analysis platform. 

NGL Fine-Chem Balance Sheet Overview

Analyzing the NGL Fine-Chem Balance Sheet reveals a steady increase in total liabilities and assets over the period from March 2020 to March 2024. The data shows total liabilities grew from Rs. 155.58 Cr in March 2020 to Rs. 353.05 Cr by March 2024. Similarly, assets also paralleled this growth, maintaining balance as per the principles of accounting.

NGL Fine-Chem Increase in Reserves

There has been a significant boost in NGL Fine-Chem's total reserves, increasing from Rs. 98.12 Cr in March 2020 to Rs. 259.72 Cr by March 2024. This growth in reserves highlights the company's enhanced internal strength and financial stability over the years.

NGL Fine-Chem Debt Reduction

The company has demonstrated effective debt management with total borrowings decreasing dramatically from Rs. 8.32 Cr in March 2020 to just Rs. 0.74 Cr by March 2024. This reduction in debt underlines NGL Fine-Chem's commitment to maintaining a robust financial structure.

NGL Fine-Chem Asset Growth

The asset side of the balance sheet also saw a progressive increase, primarily in the current assets segment, which rose from Rs. 82.65 Cr in 2020 to Rs. 203.69 Cr by 2024. Significant growth in Capital WIP (Work In Progress) from nearly zero in 2020 to Rs. 45.52 Cr in 2024 suggests substantial ongoing project investments.

The above data is an analysis for the Standalone Balance Sheet of NGL Fine-Chem.

NGL Fine-Chem's financial trends are crucial for investors watching the pharmaceutical sector closely, especially considering market volatility and investment opportunities like IPOs and sectoral growth indices.

Read More
X